Gamma-delta T cell platform encompassing allogeneic, autologous, iPSC, and genetically modified cell therapy approaches, plus T cell engagers; disease focus: cancer and autoimmune diseases

INB-600

Proprietary gamma-delta T cell engager (TCE) platform engaging both Vd1+ and Vd2+ TCR populations; disease focus: solid tumors, hematologic malignancies, autoimmune diseases

Biotech Distilled coverage (3)

2026-07-09 UPDATE: IN8bio (INAB) - The JCO Stamp Lands, the Tape Ignores It
2026-06-02 UPDATE: IN8bio (INAB) - The Survival Curve Keeps Separating, and the ATM Spigot Just Turned On 🔒 Paid
2026-05-14 IN8bio (INAB) - Scientific Deep Dive for Lead and Pipeline Products 🔒 Paid

Articles open on Substack. Some deep dives are subscriber-only.

Pipeline (6 active programs)

INB-100

DeltEx DRI

INB-400

INB-619

INB-300

INB-500

Technology platforms

DeltEx

INB-600

Biotech Distilled coverage (3)